CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-29 | BAUMGARTNER ROBERT V Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | STEER RANDOLPH C Director | Grant or award | +391 | 5,112 | ||
| 2020-10-29 | STEER RANDOLPH C Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | VESSEY RUPERT Director | Grant or award | +391 | 1,033 | ||
| 2020-10-29 | VESSEY RUPERT Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | Nusse Roeland Director | Grant or award | +391 | 12,765 | ||
| 2020-10-29 | Nusse Roeland Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | KEEGAN JOSEPH D Director | Grant or award | +391 | 2,139 | ||
| 2020-10-29 | KEEGAN JOSEPH D Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | HIGGINS JOHN L Director | Grant or award | +391 | 4,412 | ||
| 2020-10-29 | HIGGINS JOHN L Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | Bushman Julie L Director | Grant or award | +391 | 480 | ||
| 2020-10-29 | Bushman Julie L Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-29 | Seth Alpna Director | Grant or award | +391 | 2,139 | ||
| 2020-10-29 | Seth Alpna Director | Grant or award · Stock Option (Right to Buy) | +1,507 | 1,507 | ||
| 2020-10-05 | Hippel James Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −8,809 | 0 | ||
| 2020-08-09 | Furlow Brenda S. SVP - General Counsel | Option exercise | +1,724 | 6,035 | ||
| 2020-08-09 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −849 | $265.76 | $226K | 5,186 |
| 2020-08-09 | Furlow Brenda S. SVP - General Counsel | Option exercise · Restricted Stock Units | −1,724 | 0 | ||
| 2020-08-09 | Eansor Norman David President-Protein Sciences | Option exercise | +2,174 | 2,174 |
Page 40 of 53 · 1,043 trades